Twist Bioscience Corporation
TWST · FY2025 · Fiscal year ended Sep 30, 2025 · 10-K filed Nov 2025
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $377M | $313M | +20.3% |
| Operating income | −$136M | −$221M | +38.3% |
| Net income | −$77.7M | −$209M | +62.8% |
Latest quarter: Q4 FY2026
Form 10-K · Three months ended Sep 30, 2026 (fourth quarter, from the 10-K) · filed Nov 16, 2026
| $ | Q4 FY2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $127M | $99.0M | +27.9% |
| Operating income | −$24.4M | −$29.9M | +18.4% |
| Net income | −$20.6M | −$27.1M | +24.0% |
Q4 FY2026 dashboardQ4 FY2026 infographic
Questions
- What was Twist's revenue in FY2025?
- $377M in FY2025 (Fiscal year ended Sep 30, 2025), +20.3% vs $313M a year earlier, per its 10-K filed Nov 2025.
- Was Twist profitable in FY2025?
- No: net income was −$77.7M and operating income −$136M in FY2025.
- What was Twist's revenue in Q4 FY2026?
- $127M (+27.9% vs a year earlier), per its Form 10-K filed Nov 16, 2026.